PatientsVille.com Logo

PatientsVille

Onbrez Side Effects

Common Onbrez Side Effects


The most commonly reported Onbrez side effects (click to view or check a box to report):

Dyspnoea (92)
Death (60)
Cough (45)
Pneumonia (29)
Chronic Obstructive Pulmonary Disease (29)
Lung Disorder (26)
Malaise (26)
Arrhythmia (24)
Chest Pain (20)
Respiratory Disorder (17)
Fatigue (17)
Hypertension (16)
Off Label Use (14)
Respiratory Failure (13)
Myocardial Infarction (13)
Lung Neoplasm Malignant (13)
Bronchitis (13)
Fall (12)
Asthma (12)
Tachycardia (11)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Onbrez Side Effects Reported to FDA

The following Onbrez reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Onbrez on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Thyroiditis, Malaise, Oral Pain, Neck Mass, Weight Fluctuation
This is a report of a 79-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED, suffering from the following symptoms/conditions: chronic obstructive pulmonary disease,emphysema, who was treated with Onbrez (dosage: 150 Ug, Qd, start time: May 08, 2011), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Thyroiditis
  • Malaise
  • Oral Pain
  • Neck Mass
  • Weight Fluctuation
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Onbrez treatment in female patients, resulting in thyroiditis side effect.

Blood Pressure Fluctuation
This report suggests a potential Onbrez Blood Pressure Fluctuation side effect(s) that can have serious consequences. A 65-year-old male patient (weight: NA) from BG was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease,hypertension and used Onbrez (dosage: 150 Ug, Qd (once A Day)) starting 201312. Soon after starting Onbrez the patient began experiencing various side effects, including:
  • Blood Pressure Fluctuation
Drugs used concurrently:
  • Antihypertensives (Unk)
Although Onbrez demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as blood pressure fluctuation, may still occur.

Lung Cancer Metastatic, Chronic Obstructive Pulmonary Disease, Bronchial Carcinoma
This Lung Cancer Metastatic, Chronic Obstructive Pulmonary Disease, Bronchial Carcinoma problem was reported by a physician from BE. A 53-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease. On May 10, 2013 this consumer started treatment with Onbrez (dosage: 150 Ug, Qd). The following drugs were being taken at the same time:
  • Salbutamol (Unk)
  • Ipratropium Bromide (Unk)
When commencing Onbrez, the patient experienced the following unwanted symptoms/side effects:
  • Lung Cancer Metastatic
  • Chronic Obstructive Pulmonary Disease
  • Bronchial Carcinoma
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as lung cancer metastatic, may become evident only after a product is in use by the general population.

Urinary Tract Infection, Thyroid Disorder, Cardiomegaly, Pneumonia, Dyspnoea, Arthropathy, Sleep Disorder, Gastrointestinal Disorder, Blood Pressure Increased
This is a report of a 75-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: bronchial disorder,off label use,hypertension and was treated with Onbrez (dosage: 1 Df, Daily) starting 201312. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Urinary Tract Infection
  • Thyroid Disorder
  • Cardiomegaly
  • Pneumonia
  • Dyspnoea
  • Arthropathy
  • Sleep Disorder
  • Gastrointestinal Disorder
  • Blood Pressure Increased
This opens a possibility that Onbrez treatment could cause the above reactions, including urinary tract infection, and some female subjects may be more susceptible.


Haemorrhage, Prostatomegaly, Dyspnoea, Insomnia, Increased Upper Airway Secretion, Nasal Disorder, Cough
A 70-year-old male patient (weight: NA) from MX with the following symptoms/conditions: bronchial disorder,nasal congestion,off label use started Onbrez treatment (dosage: 150 Ug, Qid) on Dec 26, 2013. Soon after starting Onbrez treatment, the subject experienced various side effects, including:
  • Haemorrhage
  • Prostatomegaly
  • Dyspnoea
  • Insomnia
  • Increased Upper Airway Secretion
  • Nasal Disorder
  • Cough
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Onbrez.

Arrhythmia, Fibromyalgia, Respiratory Disorder, Sleep Disorder, Bronchitis, Arthralgia
A 54-year-old male patient from MX (weight: NA) experienced symptoms, such as: chronic obstructive pulmonary disease,asthmatic crisis and was treated with Onbrez(dosage: Unk Ukn, Daily). The treatment was initiated on 201210. After that a consumer reported the following side effect(s):
  • Arrhythmia
  • Fibromyalgia
  • Respiratory Disorder
  • Sleep Disorder
  • Bronchitis
  • Arthralgia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Onbrez efficacy:
  • Miflonide (2 Df, (2 Capsules Per Day))
  • Miflonide
  • Ambroxol (Unk Ukn, Unk)
  • Omeprazol (1 Ukn, Daily)
  • Omeprazol
  • Norfaben M (1 Ukn, Daily)
  • Oxygen (Unk Ukn, Unk)
  • Continuous Positive Airway Pressure (Unk Ukn, Unk)


Respiratory Disorder
In this report, Onbrez was administered for the following condition: chronic obstructive pulmonary disease.A 56-year-old female consumer from COUNTRY NOT SPECIFIED (weight: NA) started Onbrez treatment (dosage: 300 Ug, Qd) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Respiratory Disorder
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Onbrez treatment could be related to the listed above side effect(s).

Cardio-respiratory Arrest, Pneumonia, Lung Disorder, Renal Disorder, Infection
This is a report of the following Onbrez side effect(s):
  • Cardio-respiratory Arrest
  • Pneumonia
  • Lung Disorder
  • Renal Disorder
  • Infection
A 77-year-old male patient from COUNTRY NOT SPECIFIED (weight: NA) presented with the following condition: chronic obstructive pulmonary disease and received a treatment with Onbrez (dosage: Unk Ukn, Qd) starting: 201312.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Onbrez treatment could be associated with the listed above side effect(s).

Blood Pressure Increased, Headache
This Onbrez report was submitted by a 67-year-old female consumer from MX (weight: NA). The patient was diagnosed with: asthma,off label use and Onbrez was administered (dosage: 150 Ug, Qd) starting: 201311. The consumer developed a set of symptoms:
  • Blood Pressure Increased
  • Headache
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Onbrez treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Respiratory Arrest, Coma, Myoclonic Epilepsy, Hemiplegia
This is a report of a possible correlation between Onbrez use and the following symptoms/side effect(s):
  • Respiratory Arrest
  • Coma
  • Myoclonic Epilepsy
  • Hemiplegia
which could contribute to an assessment of Onbrez risk profile.A 69-year-old female consumer from BR (weight: NA) was suffering from chronic obstructive pulmonary disease and was treated with Onbrez (dosage: 300 Ug, Daily) starting 201306.Other concurrent medications:
  • Spiriva (2 Df, Daily)
  • Oximax (1 Df, Daily)
The patient was hospitalized.

Spinal Pain, Malaise
A female patient from COUNTRY NOT SPECIFIED (weight: NA) presented with the following symptoms: bronchiectasis,blood cholesterol,arrhythmia,blood pressure and after a treatment with Onbrez (dosage: 2 Df, Qd Once In The Morning) experienced the following side effect(s):
  • Spinal Pain
  • Malaise
The treatment was started on Jan 31, 2014. Onbrez was used in combination with the following drugs:
  • Simvastatin (40 Mg)
  • Cardizem (Unk)
  • Cardizem
The patient was hospitalized.This report could alert potential Onbrez consumers.

Cerebrovascular Accident
In this report, a 87-year-old male patient from BR (weight: NA) was affected by a possible Onbrez side effect.The patient was diagnosed with NA. After a treatment with Onbrez (dosage: 150 Ug, Unk, start date: Feb 10, 2014), the patient experienced the following side effect(s):
  • Cerebrovascular Accident
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Onbrez treatment.

Respiratory Disorder, Bronchiectasis, Secretion Discharge
This is a report of a 74-year-old female patient from BR (weight: NA), who used Onbrez (dosage: 150 Ug, Unk) for a treatment of respiratory disorder. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Respiratory Disorder
  • Bronchiectasis
  • Secretion Discharge
The following drugs could possibly have interacted with the Onbrez treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Onbrez treatment could be related to side effect(s), such as Respiratory Disorder, Bronchiectasis, Secretion Discharge.

Tongue Discolouration, Dysphagia, Oropharyngeal Pain
This tongue discolouration side effect was reported by a health professional from SE. A 73-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Onbrez (dosage: 150 Ug), which was started on NS. Concurrently used drugs: NA. When starting to take Onbrez the consumer reported the following symptoms:
  • Tongue Discolouration
  • Dysphagia
  • Oropharyngeal Pain
These side effects may potentially be related to Onbrez.

Lung Neoplasm Malignant, Arrhythmia, Pneumonia, Feeling Cold
This is a Onbrez side effect report of a male patient (weight:NA) from COUNTRY NOT SPECIFIED, suffering from the following symptoms/conditions: dyspnoea,off label use,respiratory disorder,blood pressure increased,arrhythmia,anaemia,constipation, who was treated with Onbrez (dosage:150 Mg, Morning, start time: Oct 20, 2013), combined with: NA., and developed a serious reaction and a lung neoplasm malignant side effect. The patient presented with:
  • Lung Neoplasm Malignant
  • Arrhythmia
  • Pneumonia
  • Feeling Cold
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Onbrez treatment in male patients suffering from dyspnoea,off label use,respiratory disorder,blood pressure increased,arrhythmia,anaemia,constipation, resulting in lung neoplasm malignant.

Candida Infection, Malaise, Dyspnoea, Increased Upper Airway Secretion, Secretion Discharge, Oropharyngeal Pain
This report suggests a potential Onbrez candida infection side effect(s) that can have serious consequences. A 77-year-old male patient from COUNTRY NOT SPECIFIED (weight:NA) was diagnosed with the following health condition(s): pulmonary valve incompetence,off label use and used Onbrez (dosage: 150 Ug, Daily) starting 201310. Soon after starting Onbrez the patient began experiencing various side effects, including:
  • Candida Infection
  • Malaise
  • Dyspnoea
  • Increased Upper Airway Secretion
  • Secretion Discharge
  • Oropharyngeal Pain
Drugs used concurrently:NA. Although Onbrez demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as candida infection, may still occur.

Neoplasm Malignant
This neoplasm malignant problem was reported by a consumer or non-health professional from COUNTRY NOT SPECIFIED. A 75-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On NS a consumer started treatment with Onbrez (dosage: 150 Ug, Unk). The following drugs/medications were being taken at the same time: NA. When commencing Onbrez, the patient experienced the following unwanted symptoms /side effects:
  • Neoplasm Malignant
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as neoplasm malignant, may become evident only after a product is in use by the general population.

Bronchial Obstruction, Influenza, Cough
This is a Onbrez side effect report of a 59-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: bronchiectasis,off label use and was treated with Onbrez (dosage: 1 (unk), Daily) starting 2008. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Bronchial Obstruction
  • Influenza
  • Cough
This opens a possibility that Onbrez could cause bronchial obstruction and that some female patients may be more susceptible.


A 86-year-old male patient (weight: NA) from MX with the following symptoms: chronic obstructive pulmonary disease started Onbrez treatment (dosage: 150 Ug, Daily) on 201310. Soon after starting Onbrez treatment, the consumer experienced several side effects, including:
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Onbrez side effects, such as death.

    Prostatic Disorder, Renal Cyst, Anaemia
    This prostatic disorder side effect was reported by a consumer or non-health professional from MX. A 84-year-old male patient (weight:NA) experienced the following symptoms/conditions: chronic obstructive pulmonary disease,osteoporosis,abdominal discomfort,hypertension,lung disorder,dyspepsia,pain,cardiac disorder,eye disorder.The patient was prescribed Onbrez (dosage: 300 Ug, Daily), which was started on NS. Concurrently used drugs:
    • Calcium (4 Ukn, Daily)
    • Omeprazole (2 Ukn, Daily)
    • Crestor (1 Ukn, Daily)
    • Seretide (2 Ukn, Daily)
    • Senokot//sennoside A+b (1 Ukn, Daily)
    • Tylenol (Unk (1 Or 3 ) Daily)
    • Aspirin (1 Ukn, Daily)
    • Ocuvite Adult 50+ /06822201/ (1 Ukn, Daily)
    .When starting to take Onbrez the consumer reported symptoms, such as:
    • Prostatic Disorder
    • Renal Cyst
    • Anaemia
    These side effects may potentially be related to Onbrez.

    Pneumonia, Influenza
    This is a report of a 37-year-old female patient (weight: NA) from MX, suffering from the following symptoms/conditions: NA, who was treated with Onbrez (dosage: 300 Ug, Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Pneumonia
    • Influenza
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Onbrez treatment in female patients, resulting in pneumonia side effect. The patient was hospitalized.

    Cardio-respiratory Arrest
    This report suggests a potential Onbrez Cardio-respiratory Arrest side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from COUNTRY NOT SPECIFIED was diagnosed with the following symptoms/conditions: dyspnoea,off label use and used Onbrez (dosage: 300 Ug, Qd) starting 201307. Soon after starting Onbrez the patient began experiencing various side effects, including:
    • Cardio-respiratory Arrest
    Drugs used concurrently: NA. Although Onbrez demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cardio-respiratory arrest, may still occur.

    Vomiting, Weight Decreased, Cough
    This Vomiting, Weight Decreased, Cough problem was reported by a consumer or non-health professional from COUNTRY NOT SPECIFIED. A 36-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On 201312 this consumer started treatment with Onbrez (dosage: Unk). The following drugs were being taken at the same time: NA. When commencing Onbrez, the patient experienced the following unwanted symptoms/side effects:
    • Vomiting
    • Weight Decreased
    • Cough
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as vomiting, may become evident only after a product is in use by the general population.

    Aphasia
    This is a report of a 70-year-old male patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: chronic obstructive pulmonary disease and was treated with Onbrez (dosage: 300 Ug, Qd) starting 201102. Concurrently used drugs:
    • Spiriva (1 Df, Qd)
    Soon after that, the consumer experienced the following side effects:
    • Aphasia
    This opens a possibility that Onbrez treatment could cause the above reactions, including death, and some male subjects may be more susceptible.

    Mucosal Hyperaemia
    A 84-year-old female patient (weight: NA) from BR with the following symptoms/conditions: chronic obstructive pulmonary disease started Onbrez treatment (dosage: 1 Df, Qd, Approximatel 20 Day Ago) on NS. Soon after starting Onbrez treatment, the subject experienced various side effects, including:
    • Mucosal Hyperaemia
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Onbrez.

    1 of 22 



    Top 10 Onbrez Side Effects for Women

    Women Side EffectsReports
    Dyspnoea 32
    Cough 22
    Death 22
    Fatigue 10
    Malaise 10
    Chronic Obstructive Pulmonary Disease 9
    Pneumonia 9
    Bronchitis 8
    Influenza 8
    Lung Disorder 8

    Top 10 Onbrez Side Effects for Men

    Men Side EffectsReports
    Dyspnoea 60
    Death 37
    Cough 22
    Pneumonia 20
    Chronic Obstructive Pulmonary Disease 19
    Lung Disorder 18
    Arrhythmia 17
    Malaise 16
    Chest Pain 14
    Lung Neoplasm Malignant 11

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Onbrez Side Effects

    Did You Have a Onbrez Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Onbrez for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Onbrez Safety Alerts, Active Ingredients, Usage Information

    More About Onbrez

    Side Effects reported to FDA: 538

    Onbrez safety alerts: No

    Reported deaths: 167

    Reported hospitalizations: 219

    Latest Onbrez clinical trials

    Onbrez Reviews

    No reviews, be a first to report a side effect via side effect reporting form